Kikuchi Yoshimi, Genka Ikumi, Ishizaki Azumi, Sunagawa Keishin, Yasuoka Akira, Oka Shinichi
AIDS Clinical Center, International Medical Center of Japan, Tokyo.
Clin Infect Dis. 2002 Aug 15;35(4):488-90. doi: 10.1086/341975. Epub 2002 Jul 17.
We describe 2 patients with acquired immunodeficiency syndrome who had potentially fatal bradyarrhythmia that occurred shortly after commencement of antiretroviral therapy. Lopinavir-ritonavir was the only drug that both patients were using.
我们描述了2例获得性免疫缺陷综合征患者,他们在开始抗逆转录病毒治疗后不久出现了可能致命的缓慢性心律失常。洛匹那韦-利托那韦是这两名患者都在使用的唯一药物。